Please use this identifier to cite or link to this item:
Title: When Combined with Colistin, an Otherwise Ineffective Rifampicin-Linezolid Combination Becomes Active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii
Author: Armengol, Eva
Asunción, Teresa
Viñas, Miquel
Sierra Ortigosa, Josep Maria
Keywords: Pseudomonas
Escheríchia coli
Escherichia coli
Issue Date: 8-Jan-2020
Publisher: MDPI
Abstract: The synergistic action of colistin, with two antibiotics active in Gram-positive bacteria but unable to kill gram negatives (linezolid and rifampicin), was investigated, since triple combinations are emerging as a tool to overtake multidrug resistance. Checkerboard determinations demonstrated that, when combined with colistin, the combination of linezolid and rifampicin turns active in multidrug-resistant Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. Thus, the presence of sublethal concentrations of colistin resulted in a strongly synergistic interaction between these two drugs. Moreover, the minimum inhibitory concentrations of linezolid-rifampicin combinations in the presence of colistin were lower than the maximal concentrations of these antimicrobials ain blood. These findings suggest the use of this triple combination as an effective treatment of multidrug-resistant (MDR) bacterial infections.
Note: Reproducció del document publicat a:
It is part of: Microorganisms, 2020, vol. 87, num. 1
Related resource:
ISSN: 2076-2607
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
699405.pdf265.99 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons